Market Overview
The European veterinary healthcare market covers pharmaceuticals, biologics, diagnostics, and veterinary services for both companion and production animals. It represents one of the largest regional animal health markets globally, supported by established regulatory frameworks and high standards of animal welfare. The market spans Western Europe's mature economies as well as Eastern Europe's growing demand for veterinary products.
- •Market valued at approximately $17.46 billion in 2025 with steady growth trajectory
- •Includes veterinary pharmaceuticals, vaccines, parasiticides, diagnostics, and clinical services
- •Regulated by the European Medicines Agency and national veterinary authorities across member states
Growth Drivers
Rising pet adoption and the trend toward pet humanization in Europe fuel demand for companion animal healthcare products and services. Increased livestock production and food security concerns drive investment in animal health solutions for the agricultural sector. Growing awareness of zoonotic diseases and antimicrobial resistance has heightened focus on preventive care and vaccination programs.
- •Growing companion animal population with increased spending on pet health and wellness
- •Livestock sector demands for disease prevention to ensure food safety and farm productivity
- •Stringent EU animal health regulations promoting vaccination and disease surveillance programs
Segmentation and Regional Analysis
The market is segmented by product type, including pharmaceuticals, vaccines, diagnostics, and veterinary services, with pharmaceuticals representing the largest share. Companion animals, particularly dogs and cats, dominate the market, while livestock animals including cattle, swine, and poultry constitute a significant segment. Western Europe, led by countries such as Germany, France, and the United Kingdom, accounts for the majority of market share, with Eastern Europe showing faster growth rates due to expanding veterinary infrastructure.
- •Pharmaceuticals and vaccines comprise the largest product category
- •Companion animal segment leads in value, with livestock segment driven by food production needs
- •Western Europe holds dominant market share, with Eastern Europe showing emerging growth potential
Trends and Outlook
What are the recent trends and outlook?
Digital health technologies and telemedicine are transforming veterinary service delivery across Europe, particularly in companion animal care. Sustainable and natural product formulations are gaining traction as consumers and regulators prioritize environmental and animal welfare considerations. The market is expected to maintain robust growth through the forecast period, driven by continued pet ownership expansion, advancements in animal therapeutics, and increased investment in veterinary infrastructure across the continent.
- •Telemedicine and digital diagnostics adoption accelerating in veterinary practices
- •Demand for sustainable, low-residue animal health products growing
- •Future growth supported by R&D in biologics, precision animal health, and expanding market access in Eastern Europe
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.